<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Soniya_1234 - Latest News</title>
<link href="https://news.prfree.org/rss/soniya_1234/latest.xml"></link>
<updated>2026-07-21T20:59:54+00:00</updated>
<id>urn:uuid:cd65d87d-51e1-96bc-c16d-64463c7793ed</id>
<entry>
<title>United States Potassium Thiosulfate Fertilizer Market Growth Trends and Industry Opportunities by 2031</title>
<link href="https://news.prfree.org/@soniya_1234/united-states-potassium-thiosulfate-fertilizer-market-growth-trends-and-industry-opportunities-by-2031-z0wdclcc5kzv"></link>
<id>urn:uuid:5af2d3a6-751f-932f-704f-71529d9d1f9a</id>
<summary type="html"><![CDATA[The United States potassium thiosulfate fertilizer market is growing steadily, driven by precision agriculture adoption, demand for efficient nutrient delivery, and expanding high value crop production through 2031.]]></summary>
<updated>2026-02-10T11:29:44+00:00</updated>
</entry>
<entry>
<title>Pharma ADMET Testing Market Growth at 10.49% CAGR During 2026–2034 Driven by Rising Late-Stage Drug Failures</title>
<link href="https://news.prfree.org/@soniya_1234/pharma-admet-testing-market-growth-at-1049-cagr-during-2026-2034-driven-by-rising-late-stage-drug-failures-86f55446uvba"></link>
<id>urn:uuid:f3d3992a-4002-64fa-5004-9de3cec656bc</id>
<summary type="html"><![CDATA[The Pharma ADMET Testing Market is growing at a 10.49% CAGR during 2026–2034, driven by rising late-stage drug failures, stricter regulations, early safety screening demand, and adoption of AI and in vitro testing.]]></summary>
<updated>2026-01-28T10:26:20+00:00</updated>
</entry>
<entry>
<title>Patient-Derived Xenograft Model Market Growth Outlook 2025–2031 Highlights 13.5 Percent CAGR Fueled by Precision Oncology and Translational Research</title>
<link href="https://news.prfree.org/@soniya_1234/patient-derived-xenograft-model-market-growth-outlook-2025-2031-highlights-135-percent-cagr-fueled-by-precision-oncology-and-translational-research-mwtln1qhmci3"></link>
<id>urn:uuid:0b0becaa-d728-56a7-e44e-d2b37bc393c4</id>
<summary type="html"><![CDATA[The patient-derived xenograft model market is set to grow at a 13.5 percent CAGR from 2025 to 2031, driven by precision oncology, translational research, rising cancer cases, and increasing adoption of predictive preclinical models.]]></summary>
<updated>2026-01-27T07:16:40+00:00</updated>
</entry>
</feed>